Impaza lozenges, No. 20

Erectile dysfunction (erectile dysfunction) of various origins.
Vegetative disorders of menopause in men (weakness, fatigue, decreased physical activity, decreased libido, etc.).

At a time - 1 tablet (keep in the mouth until completely dissolved - not during meals).

Regular reception.
To stabilize sexual potency (the ability to have sexual intercourse), a therapeutic and prophylactic course of at least 12 weeks is recommended. Depending on the severity of erectile dysfunction, the frequency of administration may vary: from 1 tablet every other day to two doses of a tablet daily, preferably in the evening.
If necessary, the course therapy can be repeated after 3-6 months.

Periodic reception.
For occasional stimulation of an erection, the drug is taken before intercourse, 2 tablets 1-2 hours before the expected proximity.

Active ingredients:

Affinity purified antibodies to endothelial NO synthase - 0.003 g *
Excipients:
lactose monohydrate 0.267 g, microcrystalline cellulose 0.03 g, magnesium stearate 0.003 g

* applied to lactose monohydrate in the form of a water-alcohol mixture with a content of not more than 10-15 ng / g of the active form of the active substance

Increased individual sensitivity to the components of the drug.

Tradename:

IMPASE

Dosage form:

lozenges

Composition (for 1 tablet)

Active ingredients:

Affinity purified antibodies to endothelial NO synthase - 0.003 g *
Excipients:
lactose monohydrate 0.267 g, microcrystalline cellulose 0.03 g, magnesium stearate 0.003 g

* applied to lactose monohydrate in the form of a water-alcohol mixture with a content of not more than 10-15 ng / g of the active form of the active substance

Description

Tablets of a flat-cylindrical shape with a score and a bevel, from white to almost white.
The flat side with scribble has the inscription MATERIA MEDICA, the other flat side has the inscription IMPAZA.

Pharmacotherapeutic group

Drugs for the treatment of erectile dysfunction.

ATX code: G04BE

pharmachologic effect

Increases the activity of endothelial NO-synthase, restores the production of nitric oxide (NO) by the endothelium during sexual stimulation, increases the content of cyclic guanosine monophosphate (cGMP) in smooth muscles and promotes their relaxation, which leads to an increase in the blood filling of the corpus cavernosum and provides sufficient strength and duration an erection.
The drug increases libido (sex drive) and satisfaction with intercourse.
Regular use of the drug increases serum testosterone levels (with a moderately reduced baseline).

Indications for use

Erectile dysfunction (erectile dysfunction) of various origins.
Vegetative disorders of menopause in men (weakness, fatigue, decreased physical activity, decreased libido, etc.).

Contraindications

Increased individual sensitivity to the components of the drug.

Method of administration and dosage

At a time - 1 tablet (keep in the mouth until completely dissolved - not during meals).

Regular reception.
To stabilize sexual potency (the ability to have sexual intercourse), a therapeutic and prophylactic course of at least 12 weeks is recommended. Depending on the severity of erectile dysfunction, the frequency of administration may vary: from 1 tablet every other day to two doses of a tablet daily, preferably in the evening.
If necessary, the course therapy can be repeated after 3-6 months.

Periodic reception.
For occasional stimulation of an erection, the drug is taken before intercourse, 2 tablets 1-2 hours before the expected proximity.

Side effect

When using the drug for the indicated indications and in the indicated dosages, no side effects were detected.
Possible reactions of increased individual sensitivity to the components of the drug.

Overdose

In case of an accidental overdose, dyspeptic symptoms are possible due to the fillers included in the dosage form.

Interaction with other medicinal products

It is possible to use Impaza while taking nitrates in patients with ischemic heart disease (angina pectoris I-II functional class), as well as use in conjunction with beta-blockers, diuretics, angiotensin-converting enzyme (ACE) inhibitors, calcium antagonists.

special instructions

The drug contains lactose monohydrate, and therefore it is not recommended to prescribe it to patients with congenital galactosemia, glucose or galactose malabsorption syndrome, or congenital lactase deficiency.

Release form

Lozenges. 20 tablets in a blister strip made of polyvinyl chloride film and aluminum foil.
1, 2 or 5 blister packs, together with instructions for medical use, are placed in a cardboard box.

Storage conditions

At a temperature not higher than 25 ? C.
Keep out of the reach of children.
During the period of use of the drug, store the blister strip in a cardboard box provided by the manufacturer.

Shelf life

3 years.
Do not use after the expiration date.

Conditions of dispensing from pharmacies

Without recipe.